KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mgp Ingredients (MGPI) Receivables (2016 - 2025)

Mgp Ingredients (MGPI) has disclosed Receivables for 16 consecutive years, with $116.2 million as the latest value for Q4 2025.

  • On a quarterly basis, Receivables fell 21.77% to $116.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $116.2 million, a 21.77% decrease, with the full-year FY2025 number at $116.2 million, down 21.77% from a year prior.
  • Receivables was $116.2 million for Q4 2025 at Mgp Ingredients, up from $106.7 million in the prior quarter.
  • In the past five years, Receivables ranged from a high of $159.0 million in Q2 2024 to a low of $67.1 million in Q1 2021.
  • A 5-year average of $116.4 million and a median of $112.7 million in 2022 define the central range for Receivables.
  • Peak YoY movement for Receivables: skyrocketed 75.06% in 2021, then decreased 26.3% in 2025.
  • Mgp Ingredients' Receivables stood at $99.7 million in 2021, then increased by 9.57% to $109.3 million in 2022, then skyrocketed by 32.05% to $144.3 million in 2023, then rose by 2.91% to $148.5 million in 2024, then dropped by 21.77% to $116.2 million in 2025.
  • Per Business Quant, the three most recent readings for MGPI's Receivables are $116.2 million (Q4 2025), $106.7 million (Q3 2025), and $117.2 million (Q2 2025).